(Q44123157)

30 November 2017

Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen (English)

1 reference

30 November 2017

Mark Frederick McCarty

series ordinal

1

object named as

McCarty MF

1 reference

30 November 2017

1 September 2002

1 reference

30 November 2017

1 reference

30 November 2017

59

1 reference

30 November 2017

3

1 reference

30 November 2017

268-279

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Can the clinical efficacy of the HMG CoA reductase inhibitors be explained solely by their effects on LDL-cholesterol?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

[HMG-CoA reductase inhibitor and risk of stroke]

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Rho GTPases and signaling networks

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Targeting Rho in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Role of nuclear factor-kappa B in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Modulation of vascular cell activation, function, and apoptosis: role of antioxidants and nuclear factor-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

1 reference

7 January 2021

Vascular nitric oxide may lessen Alzheimer's risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute-phase cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Oral statins and increased bone-mineral density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Hyperinsulinemia potentiates activation of p21Ras by growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Insulin promotes phosphorylation and activation of geranylgeranyltransferase II. Studies with geranylgeranylation of rab-3 and rab-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The Akt kinase signals directly to endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Insulin's stimulation of endothelial superoxide generation may reflect up-regulation of isoprenyl transferase activity that promotes rac translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Carcinogenicity of policosanol in Sprague Dawley rats: a 24 month study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Teratogenic and reproductive studies of policosanol in the rat and rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

A 12-month study of policosanol oral toxicity in Sprague Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of policosanol chronically administered in male monkeys (Macaca arctoides)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Toxicity of policosanol in beagle dogs: one-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Carcinogenicity of policosanol in mice: an 18-month study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Multigeneration reproduction study of policosanol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Evaluation of peri- and post-natal toxicity of Policosanol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Treatment of hypercholesterolemia in NIDDM with policosanol

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of policosanol on postmenopausal women with type II hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of policosanol successive dose increases on platelet aggregation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

A long-term study of policosanol in the treatment of intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of policosanol on intimal thickening in rabbit cuffed carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

A comparative study of policosanol vs lovastatin on intimal thickening in rabbit cuffed carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of policosanol on cerebral ischemia in Mongolian gerbils: role of prostacyclin and thromboxane A2

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of policosanol on cerebral ischemia in Mongolian gerbils.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Response of hypercholesterolemic subjects to administration of tocotrienols

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Metabolic effects of a low-glycemic-index diet

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Intensive lifestyle changes for reversal of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Blood rheology in vegetarians

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Failure to reduce cholesterol as explanation for the limited efficacy of antihypertensive treatment in the reduction of CHD. Examination of the evidence from six hypertension intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Diet and exercise in the treatment of NIDDM. The need for early emphasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Blood pressure in vegetarians.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Vegetarian diet and blood pressure levels: incidental or causal association?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Taurine modulates platelet aggregation in cats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Blood pressure and metabolic changes during dietary L-arginine supplementation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Can we recommend fish oil for hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Coenzyme Q10 in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Does potassium supplementation lower blood pressure? A meta-analysis of published trials

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Atherogenesis and the arginine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

L-carnitine treatment for congestive heart failure--experimental and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Oxidants downstream from superoxide inhibit nitric oxide production by vascular endothelium--a key role for selenium-dependent enzymes in vascular health

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

Up-regulation of endothelial nitric oxide activity as a central strategy for prevention of ischemic stroke - just say NO to stroke!

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900226-8

7 January 2021

10.1016/S0306-9877(02)00226-8

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12208152